{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:28:04Z","timestamp":1784946484583,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Tatyana Klimova for editing of this work"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.virol.2014.12.002","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T06:51:02Z","timestamp":1418971862000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses"],"prefix":"10.1016","volume":"476","author":[{"given":"C\u00e9sar G.","family":"Albari\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Wiggleton Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke S.","family":"Uebelhoer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayan K.","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart T.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Towner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2014.12.002_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virol.2013.04.014","article-title":"Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012","volume":"442","author":"Albarino","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2014.12.002_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.virol.2013.07.038","article-title":"Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate","volume":"446","author":"Albarino","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2014.12.002_bib3","doi-asserted-by":"crossref","first-page":"e1002916","DOI":"10.1371\/journal.ppat.1002916","article-title":"Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism","volume":"8","author":"Bale","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2014.12.002_bib4","doi-asserted-by":"crossref","first-page":"10385","DOI":"10.1128\/JVI.01452-13","article-title":"Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism","volume":"87","author":"Bale","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib5","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.173.6.3925","article-title":"Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus","volume":"173","author":"Basler","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2014.12.002_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4161\/viru.2.2.15481","article-title":"Differential recognition of viral RNA by RIG-I","volume":"2","author":"Baum","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.virol.2014.12.002_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter","volume":"73","author":"Buchholz","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib8","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/JVI.02199-05","article-title":"Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha\/beta interferon production induced by RIG-I signaling","volume":"80","author":"Cardenas","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.celrep.2014.01.043","article-title":"The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway","volume":"6","author":"Edwards","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.virol.2014.12.002_bib10","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JVI.01160-10","article-title":"Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway","volume":"85","author":"Fabozzi","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib11","series-title":"Fields Virology","first-page":"923","article-title":"Filoviridae: Marburg and Ebola viruses","author":"Feldmann","year":"2013"},{"key":"10.1016\/j.virol.2014.12.002_bib12","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/JVI.02344-07","article-title":"Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus","volume":"82","author":"Hartman","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib13","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1128\/JVI.00044-06","article-title":"Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication","volume":"80","author":"Hartman","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virol.2004.07.006","article-title":"A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus","volume":"328","author":"Hartman","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virol.2014.12.002_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cll.2009.12.001","article-title":"Ebola and marburg hemorrhagic fever","volume":"30","author":"Hartman","year":"2010","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.virol.2014.12.002_bib16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1469-0691.2011.03535.x","article-title":"Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa","volume":"17","author":"Leroy","year":"2011","journal-title":"Clin. Microbiol. Infec.: Off. Publ. Eur. Soc. Clin. Microbiol. Infec. Dis."},{"key":"10.1016\/j.virol.2014.12.002_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1073\/pnas.0807854106","article-title":"Structure of the Ebola VP35 interferon inhibitory domain","volume":"106","author":"Leung","year":"2009","journal-title":"P. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.virol.2014.12.002_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nsmb.1765","article-title":"Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35","volume":"17","author":"Leung","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2014.12.002_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.chom.2013.06.010","article-title":"Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome","author":"Luthra","year":"2013","journal-title":"Cell Host Microbe 14"},{"issue":"Suppl 3)","key":"10.1016\/j.virol.2014.12.002_bib20","doi-asserted-by":"crossref","first-page":"S1011","DOI":"10.1093\/infdis\/jir338","article-title":"VP24 is a molecular determinant of Ebola virus virulence in guinea pigs","volume":"204","author":"Mateo","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2014.12.002_bib21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1128\/JVI.01372-09","article-title":"Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling","volume":"84","author":"Mateo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2011.09.023","article-title":"Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection","volume":"422","author":"McElroy","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.virol.2014.12.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2011.08.024","article-title":"Using next generation sequencing to identify yellow fever virus in Uganda","volume":"422","author":"McMullan","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.virol.2014.12.002_bib24","doi-asserted-by":"crossref","first-page":"e1003065","DOI":"10.1371\/journal.ppat.1003065","article-title":"Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus","volume":"8","author":"Mohan","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2014.12.002_bib25","doi-asserted-by":"crossref","first-page":"e1002304","DOI":"10.1371\/journal.ppat.1002304","article-title":"Discovery of an ebolavirus-like filovirus in Europe","volume":"7","author":"Negredo","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2014.12.002_bib26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.celrep.2014.02.027","article-title":"Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1","volume":"6","author":"Page","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.virol.2014.12.002_bib27","doi-asserted-by":"crossref","first-page":"10581","DOI":"10.1128\/JVI.00925-10","article-title":"Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function","volume":"84","author":"Prins","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib28","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1128\/JVI.01875-08","article-title":"Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1","volume":"83","author":"Prins","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib29","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1128\/JVI.02459-09","article-title":"Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs","volume":"84","author":"Prins","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib30","doi-asserted-by":"crossref","first-page":"20661","DOI":"10.1073\/pnas.1213559109","article-title":"Structural basis for Marburg virus VP35-mediated immune evasion mechanisms","volume":"109","author":"Ramanan","year":"2012","journal-title":"P. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.virol.2014.12.002_bib31","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/v3091634","article-title":"Filoviral immune evasion mechanisms","volume":"3","author":"Ramanan","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2014.12.002_bib32","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation","volume":"80","author":"Reid","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib33","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1128\/JVI.01097-07","article-title":"Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1","volume":"81","author":"Reid","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2014.03.018","article-title":"High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses","volume":"106","author":"Uebelhoer","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2014.12.002_bib35","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/JVI.02575-10","article-title":"Marburg virus VP40 antagonizes interferon signaling in a species-specific manner","volume":"85","author":"Valmas","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib36","doi-asserted-by":"crossref","first-page":"e1000721","DOI":"10.1371\/journal.ppat.1000721","article-title":"Marburg virus evades interferon responses by a mechanism distinct from ebola virus","volume":"6","author":"Valmas","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2014.12.002_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/oxfordjournals.jbchem.a021379","article-title":"Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3)","volume":"120","author":"Yoneyama","year":"1996","journal-title":"J. Biochem."},{"key":"10.1016\/j.virol.2014.12.002_bib38","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/JVI.05741-11","article-title":"Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells","volume":"86","author":"Zhu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.12.002_bib39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.antiviral.2012.01.005","article-title":"dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35","volume":"93","author":"Zinzula","year":"2012","journal-title":"Antivir. Res."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682214005388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682214005388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:29:11Z","timestamp":1758587351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682214005388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":39,"alternative-id":["S0042682214005388"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2014.12.002","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}